Last reviewed · How we verify

NCT03081793

Estimation of Average and Beat-to-beat Heart Rate With a Novel Wrist-worn PPG Device in Surgery Patients

Completed Last updated 19 September 2017
What this trial tests

trial in Atrial Fibrillation in 30 participants. Completed in 30 August 2017.

Timeline
1 May 2017
Primary endpoint
30 August 2017
30 August 2017

Quick facts

Lead sponsorTampere University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date1 May 2017
Primary completion30 August 2017
Estimated completion30 August 2017
Sites1 location across Finland

Conditions studied

Sponsor

Tampere University Hospital

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to the reliability and feasibility of a novel optical heart rate monitor in hospital patients. Especially patients with atrial fibrillation are included. Patients will be monitored for two hours during routine post-operative care. The data from study device will be compared to routine monitoring. The design of the study is a Pilot feasibility study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Tampere University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03081793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing